| Dr Hung Phuoc Nguyen, MD | |
|
2841 Lomita Blvd 200, Torrance, CA 90505-5110 | |
| (310) 517-8952 | |
| (310) 517-9565 |
| Full Name | Dr Hung Phuoc Nguyen |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 16 Years |
| Location | 2841 Lomita Blvd 200, Torrance, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255590444 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | A126528 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Torrance Memorial Medical Center | Torrance, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Torrance Health Association Inc | 1355302134 | 249 |
News Archive
Alliance of Women Filmmakers was established to empower women to create diverse screen images of women. The organization produces The Los Angeles Women's International Film Festival which showcases films made by women that educate and inform audiences of social, political and health issues impacting women globally. In addition to presenting the annual festival, Alliance of Women Filmmakers is proud to support other organizations that benefit women.
The initial goal was reportedly based on flawed data and the newly set milepost has already been met. Still, The Baltimore Sun reports that the state has halted work on its small business marketplace, and that Maryland will charge for work related to public information requests about what went wrong with the website.
Inspiration Biopharmaceuticals, Inc. today reported data from its ongoing Phase 2/3 study evaluating the efficacy of OBI-1, an investigational recombinant porcine factor VIII (FVIII), for the treatment of serious bleeds in people with acquired hemophilia A. According to the interim analysis, seven out of seven trial participants receiving OBI-1 experienced control and subsequent resolution of their bleeds.
Pharmacyclics LLC today highlighted results from a sub-analysis of the Phase III RESONATE™ (PCYC-1112) trial, which found that previously-treated patients with chronic lymphocytic leukemia (CLL) who adhered to the recommended 420 mg dose of IMBRUVICA® (ibrutinib) experienced improved progression-free survival (PFS; the primary endpoint) as assessed by an Independent Review Committee (IRC), compared to patients who took lower doses or missed doses, regardless of high-risk genetic factors.
Since the implementation of the Massachusetts health insurance law in 2006, more residents have health coverage and increased access to care, but rising health care costs combined with the current economic recession could undermine some of the law's successes, according to the third annual "Update on Health Reform in Massachusetts" report by the Urban Institute, the Boston Globe reports.
› Verified 2 days ago
| Entity Name | Torrance Health Association Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083903124 PECOS PAC ID: 1355302134 Enrollment ID: O20110819000276 |
News Archive
Alliance of Women Filmmakers was established to empower women to create diverse screen images of women. The organization produces The Los Angeles Women's International Film Festival which showcases films made by women that educate and inform audiences of social, political and health issues impacting women globally. In addition to presenting the annual festival, Alliance of Women Filmmakers is proud to support other organizations that benefit women.
The initial goal was reportedly based on flawed data and the newly set milepost has already been met. Still, The Baltimore Sun reports that the state has halted work on its small business marketplace, and that Maryland will charge for work related to public information requests about what went wrong with the website.
Inspiration Biopharmaceuticals, Inc. today reported data from its ongoing Phase 2/3 study evaluating the efficacy of OBI-1, an investigational recombinant porcine factor VIII (FVIII), for the treatment of serious bleeds in people with acquired hemophilia A. According to the interim analysis, seven out of seven trial participants receiving OBI-1 experienced control and subsequent resolution of their bleeds.
Pharmacyclics LLC today highlighted results from a sub-analysis of the Phase III RESONATE™ (PCYC-1112) trial, which found that previously-treated patients with chronic lymphocytic leukemia (CLL) who adhered to the recommended 420 mg dose of IMBRUVICA® (ibrutinib) experienced improved progression-free survival (PFS; the primary endpoint) as assessed by an Independent Review Committee (IRC), compared to patients who took lower doses or missed doses, regardless of high-risk genetic factors.
Since the implementation of the Massachusetts health insurance law in 2006, more residents have health coverage and increased access to care, but rising health care costs combined with the current economic recession could undermine some of the law's successes, according to the third annual "Update on Health Reform in Massachusetts" report by the Urban Institute, the Boston Globe reports.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hung Phuoc Nguyen, MD 23326 Hawthorne Blvd 200, Torrance, CA 90505-3756 Ph: (310) 257-7205 | Dr Hung Phuoc Nguyen, MD 2841 Lomita Blvd 200, Torrance, CA 90505-5110 Ph: (310) 517-8952 |
News Archive
Alliance of Women Filmmakers was established to empower women to create diverse screen images of women. The organization produces The Los Angeles Women's International Film Festival which showcases films made by women that educate and inform audiences of social, political and health issues impacting women globally. In addition to presenting the annual festival, Alliance of Women Filmmakers is proud to support other organizations that benefit women.
The initial goal was reportedly based on flawed data and the newly set milepost has already been met. Still, The Baltimore Sun reports that the state has halted work on its small business marketplace, and that Maryland will charge for work related to public information requests about what went wrong with the website.
Inspiration Biopharmaceuticals, Inc. today reported data from its ongoing Phase 2/3 study evaluating the efficacy of OBI-1, an investigational recombinant porcine factor VIII (FVIII), for the treatment of serious bleeds in people with acquired hemophilia A. According to the interim analysis, seven out of seven trial participants receiving OBI-1 experienced control and subsequent resolution of their bleeds.
Pharmacyclics LLC today highlighted results from a sub-analysis of the Phase III RESONATE™ (PCYC-1112) trial, which found that previously-treated patients with chronic lymphocytic leukemia (CLL) who adhered to the recommended 420 mg dose of IMBRUVICA® (ibrutinib) experienced improved progression-free survival (PFS; the primary endpoint) as assessed by an Independent Review Committee (IRC), compared to patients who took lower doses or missed doses, regardless of high-risk genetic factors.
Since the implementation of the Massachusetts health insurance law in 2006, more residents have health coverage and increased access to care, but rising health care costs combined with the current economic recession could undermine some of the law's successes, according to the third annual "Update on Health Reform in Massachusetts" report by the Urban Institute, the Boston Globe reports.
› Verified 2 days ago
Deborah Chon, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3445 Pacific Coast Hwy Ste 100, Torrance, CA 90505 Phone: 310-542-6333 | |
Erika Joyce Kalash, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3565 Del Amo Blvd, Torrance, CA 90503 Phone: 310-214-0811 | |
Hosayn Khaleeli, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2245 Sepulveda Blvd, Torrance, CA 90501 Phone: 310-320-3204 Fax: 310-320-0919 | |
Mr. Anthony C Dike, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 20280 S Vermont Ave Ste 215, Torrance, CA 90502 Phone: 323-434-4626 Fax: 310-693-8082 | |
Paul J Brown, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3333 Skypark Dr, Torrance, CA 90505 Phone: 310-517-9006 | |
Dr. Philip W Chung, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2841 Lomita Blvd 215, Torrance, CA 90505 Phone: 310-379-2860 Fax: 310-325-1144 | |
Dr. Diane Jennifer Prager, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3445 Pacific Coast Hwy Ste 300, Torrance, CA 90505 Phone: 310-325-8252 |